Approval · Notice of Compliance 22506 · 2019
AG-FINASTERIDE: Notice of Compliance 22506
Issued August 6, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22506
- Date
- August 6, 2019
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AG-FINASTERIDE | 02374404 | Dormant |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB